Aromatic Calcium Channel Blocker Amlodipine from China
Amlodipine besylate is an aromatic dihydropyridine calcium channel blocker for hypertension treatment. Falls under 2942.00.05.00 as a modified aromatic drug API, distinguished from bulk medicinals in Chapter 30. Meets criteria for separate chemically defined organic compounds.
Duty Rate — China → United States
125%
Rate breakdown
9903.88.0325%Except as provided in headings 9903.88.13, 9903.88.18, 9903.88.33, 9903.88.34, 9903.88.35, 9903.88.36, 9903.88.37, 9903.88.38, 9903.88.40, 9903.88.41, 9903.88.43, 9903.88.45, 9903.88.46, 9903.88.48, 9903.88.56, 9903.88.64, 9903.88.66, 9903.88.67, 9903.88.68, or 9903.88.69, articles the product of China, as provided for in U.S. note 20(e) to this subchapter and as provided for in the subheadings enumerated in U.S. note 20(f)
9903.04.6093.5%Pharmaceuticals: patented pharma articles — 100% floor rate
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Besylate salt classification follows acid component per Chapter Note 5(C)(1)
• Provide ICH stability data confirming API status vs finished product
• Monitor for anti-dusting agents that could trigger Note (g) reclassification